等待開盤 09-20 09:30:00 美东时间
-0.010
-0.48%
Vir Biotechnology (NASDAQ:VIR) said it has appointed Jason O’Byrne as its CFO and executive vice president. The appointment is effective from October 2. Mr. O’Byrne is an industry veteran with over tw...
09-10 20:32
Caribou Biosciences- Plans to Appoint Ryan Fischesser to Assume Role of Princip...
09-04 04:03
Caribou Biosciences Inc - on Sept 1 Jason O'byrne, CFO, Informed of Intent to R...
09-04 04:02
Ratings for Caribou Biosciences (NASDAQ:CRBU) were provided by 4 analysts in th...
09-04 01:00
H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Caribou Bioscie...
09-03 22:06
Caribou Biosciences Appoints Tina Albertson, Md, Phd, as Chief Medical Officer
08-12 20:00
Caribou Biosciences Inc : BofA Global Research Cuts Price Objective to $15 From...
08-09 18:55
RBC Capital analyst Luca Issi reiterates Caribou Biosciences (NASDAQ:CRBU) with a Outperform and maintains $14 price target.
08-07 23:53
Caribou Biosciences Inc : Leerink Partners Cuts Target Price to $9 From $10
08-07 11:51
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.45) by 6.67 percent. This is a 12.5 percent increase over losses of $(0.48) per share from
08-07 05:12